BLOG & LATEST NEWS
In the evolving world of healthcare sales, few areas offer the same combination of growth, impact, and long-term career potential as Infection Prevention & Control (IPC). As the NHS and wider healthcare systems continue to prioritise patient safety and efficiency, IPC has become a strategic focus area — creating strong demand for skilled professionals with […]
Read More
IPC is evolving rapidly, influenced by global health challenges, technological innovation, and changing healthcare priorities. 🔮 Key Trends in IPC Digital Transformation Data and analytics are being used to track infection rates and improve response times. Sustainability in Healthcare There is increasing demand for eco-friendly IPC solutions that reduce waste without compromising […]
Read More
In modern healthcare, procurement and Infection Prevention & Control (IPC) are closely linked. Decisions about products and suppliers directly impact infection outcomes. 🏥 Why Procurement Matters in IPC Procurement teams are responsible for sourcing: * PPE and protective equipment * Cleaning and sterilisation products * Medical consumables * Infection control technologies […]
Read More
Healthcare-associated infections (HCAIs) affect thousands of patients every year in the UK. Effective Infection Prevention & Control (IPC) is the most powerful tool in reducing these risks. ⚠️ What Are HCAIs? HCAIs are infections patients acquire while receiving treatment in a healthcare setting. Common examples include: * MRSA * C. difficile * […]
Read More
Infection Prevention & Control (IPC) is a cornerstone of modern healthcare. From hospitals to community care settings, effective IPC practices protect patients, reduce costs, and save lives. As healthcare systems like the NHS face increasing pressure, IPC is no longer just a clinical priority — it’s a strategic focus area shaping the future of healthcare […]
Read More
Patient-centricity is increasingly at the heart of UK pharma and healthcare research. Quantitative methods allow experienced researchers to capture patient experiences, preferences, and outcomes, informing clinical strategies, market access, and commercial decision-making. Measuring Patient Preferences Discrete choice experiments (DCEs), conjoint analysis, and rating scales help quantify how patients value treatment attributes such […]
Read More
The UK pharma and healthcare sector is undergoing rapid digital transformation, and quantitative research is no exception. Emerging technologies, automation, and data-driven platforms are reshaping how researchers collect, analyse, and communicate insights. Automation in Data Collection and Analysis Digital platforms enable automated survey distribution, data cleaning, and preliminary analysis. This reduces manual effort […]
Read More
Health Economics and Outcomes Research (HEOR) is central to demonstrating the value of therapies in the UK pharmaceutical market. Quantitative researchers play a pivotal role in generating the data and insights that underpin reimbursement, pricing, and market access decisions, particularly in the context of NICE and NHS evaluation. Understanding the UK Market Context […]
Read More
In UK pharma and healthcare market research, quantitative analysis provides the evidence base for critical decisions. Yet even the most sophisticated models and datasets lose value if stakeholders cannot understand—or act on—the findings. For experienced quant researchers, communication is as important as statistical rigour. Knowing Your Audience Different stakeholders have different priorities. Clinicians […]
Read More
Real-world data (RWD) is transforming the landscape of quantitative market research in UK pharma and healthcare. By harnessing the wealth of information from NHS records, patient registries, claims data, and digital health sources, quant researchers can generate more relevant, evidence-based insights that align with clinical realities and payer expectations. The Growing Importance of RWD […]
Read More